Dimitrova M. (Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria). Публикации

№Библиографическая ссылкаГод

Статьи в журналах/сборниках из перечня Web of Science/Scopus
1Moorkens E., Godman B., Huys I., Hoxha I., Malaj A., Keuerleber S., Stockinger S., Dimitrova M., Tachkov K., Voncina L., Palcevski V.V., Achniotou G., Slabý J., Popelková L., Kohoutová K., Bartels D., Laius O., Martikainen J.E., Selke G., Kourafalos V., Magnusson E., Einarsdóttir R., Adams R., Joppi R., Allocati E., Jakupi A., Viksna A., Greičiūtė-Kuprijanov I., Bonanno P.V., Suttorp V., Melien O., Plisko R., Mardare I., Мешков Д.О., Novakovic T., Furst J., Zara C., Markovic-Pekovic V., Befrits G., Puckett R., Vulto A.G., Mortenhuber S. The expiry of Humira® market exclusivity and the entry of Adalimumab biosimilars in Europe: An overview of pricing and national policy measurese // Frontiers in Pharmacology. 2021. т 11. С. 1-17 https://www.frontiersin.org/articles/10.3389/fphar.2020.591134/full.2021
2Мешков Д.О., Bonnano P.V., Bucsics A.Н., Simoens S.Н., Martin A.P., Oortwijn W., Gulbinovic J., Rothe C.C., Timoney A., Ferrario A., Gad M., Salem A., Hoxha I., Sauermann R., Dimitrova M., Kamusheva M., Petrova G., Laius O., Selke G., Kourafalos V., Yfantopoulos J., Magnusson E., Joppi R., Jakupi A., Bochenek T., Wladysiuk M., Markovic-Pekovic V., Furtado C., Mardare I., Furst J., Tomek D., Zara C., Haycox A., Campbell S., Cortadellas M.O., Godman B. Proposal for a regulation on health technology assessment in Europe - opinions of policy makers, payers and academics from the field of HTA // Expert Review of Pharmacoeconomics and Outcomes Research. 2019. v.19, №3. С. 251-261.2019
3Ferrario A.Н., Bochenek T., Arāja D., Danko D., Catic T., Dimitrova M., Furst J., Greičiūtė-Kuprijanov I., Hoxha I., Jakupi A., Laidmäe E., Loblová O., Mardare I., Markovic´ -Pekovic V., Novakovic T., Petrova G., Pomorski M., Tomek D., Voncina L., Haycox A., Kanavos P., Bonanno P.V., Godman B., Мешков Д.О. The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications // PharmacoEconomics. 2017. Volume 35, Issue 12. С. 1271–1285 https://link.springer.com/article/10.1007%2Fs40273-017-0559-4.2017
4Moorkens E., Vulto A.G., Huys I., Dylst P., Godman B., Keuerleber S., Petrova G., Sović-Brkičić L., Slabý J., Dimitrova M., Laius O., sebesta R., Karr A., Beck M., Martikainen J.E., Selke G., Spillane S., McCullagh L., Trifirò G., Bonanno P.V., Viksna A., Wladysiuk M., Mota-Filipe H., Kalaba M., Bedrač S.M., Furst J., Zara C., Skiöld P., Magnusson E., Simoens S.Н., Bochenek T., Мешков Д.О. Policies for biosimilar uptake in Europe: An overview // Plos one. 2017. v.12(12); 2017. С. 1-17 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746224/pdf/pone.0190147.pdf).2017